Skip to Content

WPI 1118 (Mirtazapine 30 mg)

Pill with imprint WPI 1118 is Yellow, Elliptical / Oval and has been identified as Mirtazapine 30 mg. It is supplied by Watson Pharmaceuticals.

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1118

Mirtazapine

Imprint
WPI 1118
Strength
30 mg
Color
Yellow
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Tetracyclic antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-1118
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.